Epidemiology Rheumatoid Arthritis in China %E2%80%93 Rapid urbanization presents favorable market potential

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Medical Industry Week 15 DECEMBER 2014

Medical Industry Week 15 DECEMBER 2014

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 24 pages

Industry Trend Analysis - Medical Devices - 2014 Industry Trends Industry Brief - 3M Settles Latest Dental Ceramic Colouring Patent Suit With Licence Deal Industry Brief - Milestone Scientific Signs Deal For Epidural Instrument In China Industry Brief - SDRI/Joimax Sign Distribution Deal For Synergy ...

Industries: Pathology | Countries: United States, Canada, China

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • December 2014
  • 54 pages

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2023 Summary Colorectal cancer (CRC) is cancer that starts in the colon or the rectum. CRC has the third highest incidence among all cancers in men and second highest in women. CRC is a high mortality cancer, with mortality rates just behind ...

Industries: Pathology | Countries: World, Spain, Italy, France, Germany, Japan, China

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • December 2014
  • 48 pages

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 Summary Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the body's immune system attacks the lining of the joints causing an inflammatory response. RA is characterized by joint swelling, ...

Industries: Pathology | Countries: Japan, India, China, World, Australia, Spain, Italy, France, Germany, United States, United Kingdom, Europe

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

GeneNews Limited (Symbol:GEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. GeneNews Limited SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States, Canada, Malaysia, China

ViroMed Co., Ltd. (Symbol:084990) SWOT Analysis, Strategy, Revenues and Profits

ViroMed Co., Ltd. (Symbol:084990) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. ViroMed Co., Ltd. SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States, South Korea, China

Chemed Corporation (Symbol:CHE) SWOT Analysis, Strategy, Revenues and Profits

Chemed Corporation (Symbol:CHE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Chemed Corporation SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States, Philippines, Singapore, Indonesia, Mexico, Japan, China

China Shineway Pharmaceutical Group Limited (Symbol:2877) SWOT Analysis, Strategy, Revenues and Profits

China Shineway Pharmaceutical Group Limited (Symbol:2877) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. China Shineway Pharmaceutical Group Limited SWOT Analysis report provides ...

Industries: Pathology | Countries: China

Sinovac Biotech Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

Sinovac Biotech Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Sinovac Biotech Ltd. SWOT Analysis report provides you a strategic ...

Industries: Pathology | Countries: China

Sinovac Biotech Co., Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

Sinovac Biotech Co., Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Sinovac Biotech Co., Ltd. SWOT Analysis report provides you a strategic ...

Industries: Pathology | Countries: China

China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review

China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

Summary China Medical System Holdings Limited (CMS) is a pharmaceutical service provider. The company provides marketing promotion and sale of prescription drugs to all therapeutic departments in hospitals. CMS's product portfolio includes deanxit, ursofalk, exacin, xinhuosu, augentropfen stulln mono ...

Industries: Pathology | Countries: China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.